4.8 Article

The glioblastoma multiforme tumor site promotes the commitment of tumor-infiltrating lymphocytes to the TH17 lineage in humans

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

The glioblastoma multiforme tumor site promotes the commitment of tumor-infiltrating lymphocytes to the TH17 lineage in humans

Meike Mitsdoerffer et al.

Summary: Glioblastoma multiforme (GBM) shows resistance to immune responses, specifically to checkpoint inhibition. The study reveals that the brain tumor environment in GBM may cause infiltrating T helper cells to develop into type 17 T helper cells. The potential of targeting these CD4(+) TILs in the tumor-promoting milieu needs further investigation.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Biochemistry & Molecular Biology

Role of IL-6 in the commitment of T cell subsets

Thomas Korn et al.

Summary: IL-6 plays a critical role in the differentiation and maintenance of Th17 cells and T follicular helper cells, as well as in the induction of Treg cells. Its absence can impair adaptive immune responses to fungi and extracellular bacteria, while its presence is necessary for homeostasis in the gut lamina propria.

CYTOKINE (2021)

Article Oncology

Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer

Chao Liu et al.

Summary: IL-17A promotes resistance to anti-PD-1 therapy by increasing PD-L1 expression through the p65/NRF1/miR-15b-5p axis. Blocking IL-17A improves the efficacy of anti-PD-1 therapy in MSS CRC murine models, suggesting IL-17A as a potential therapeutic target to sensitize patients with MSS CRC to ICI therapy.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Multidisciplinary Sciences

A vaccine targeting mutant IDH1 in newly diagnosed glioma

Michael Platten et al.

Summary: Mutated isocitrate dehydrogenase 1 (IDH1) defines a molecularly distinct subtype of diffuse glioma. The most common IDH1 mutation in gliomas affects codon 132 and encodes IDH1(R132H), which harbours a shared clonal neoepitope that is presented on major histocompatibility complex (MHC) class II. An IDH1(R132H)-specific peptide vaccine (IDH1-vac) induces specific therapeutic T helper cell responses that are effective against IDH1(R132H)+ tumours.

NATURE (2021)

Article Oncology

Type 17 immunity promotes the exhaustion of CD8+ T cells in cancer

Byung-Seok Kim et al.

Summary: IL-17-producing cells promote terminal exhaustion of CD8(+) T cells and tumor progression in vivo, which can be reversed by blockade of IL-17 or ROR gamma t pathway. Human TCGA analyses reveal a strong positive correlation between type 17 and CD8(+) T cell exhaustion signature gene sets in multiple cancers, suggesting type 17 immunity as a promising target for cancer immunotherapy.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Review Oncology

Glial and myeloid heterogeneity in the brain tumour microenvironment

Brian M. Andersen et al.

Summary: This review discusses the immunosuppressive and tumour-promoting properties of specific cell populations in the brain tumour microenvironment, highlighting new therapeutic opportunities. The highly immunosuppressive brain tumour microenvironment differs from that of other malignancies, and recent technical advances have allowed for a better understanding of its complexity at the single-cell level. Treatment modulation of the brain TME presents potential approaches for improving outcomes in brain cancer patients.

NATURE REVIEWS CANCER (2021)

Article Biochemistry & Molecular Biology

UCell: Robust and scalable single-cell gene signature scoring

Massimo Andreatta et al.

Summary: UCell is an R package designed for evaluating gene signatures in single-cell datasets. It offers robust signature scores based on the Mann-Whitney U statistic, requiring less computing time and memory compared to other methods. UCell can handle large datasets in minutes and can interact directly with Seurat objects.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Article Biotechnology & Applied Microbiology

Immune and Clinical Features ofCD96Expression in Glioma byin silicoAnalysis

Qiang Zhang et al.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)

Article Medicine, Research & Experimental

Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors

Niklas Schaefer et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2019)

Article Biochemistry & Molecular Biology

Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma

Junfei Zhao et al.

NATURE MEDICINE (2019)

Article Immunology

CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer

Laura M. McLane et al.

Annual Review of Immunology (2019)

Article Neurosciences

Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39

Maisa C. Takenaka et al.

NATURE NEUROSCIENCE (2019)

Article Biochemistry & Molecular Biology

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

Cyril Neftel et al.

Review Immunology

Mechanisms of immunotherapy resistance: lessons from glioblastoma

Christopher M. Jackson et al.

NATURE IMMUNOLOGY (2019)

Article Oncology

T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

Karolina Woroniecka et al.

CLINICAL CANCER RESEARCH (2018)

Article Multidisciplinary Sciences

Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2 alpha

Qirui Wang et al.

NATURE COMMUNICATIONS (2018)

Review Immunology

Coming of Age: CD96 Emerges as Modulator of Immune Responses

Hristo Georgiev et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Immunology

An immunoregulatory and tissue-residency program modulated by c-MAF in human T(H)17 cells

Dominik Aschenbrenner et al.

NATURE IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

Cytokine Regulation in Human CD4 T Cells by the Aryl Hydrocarbon Receptor and Gq-Coupled Receptors

Jeremy P. McAleer et al.

SCIENTIFIC REPORTS (2018)

Article Biochemistry & Molecular Biology

Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade

Spencer C. Wei et al.

Article Multidisciplinary Sciences

The impact of amplification on differential expression analyses by RNA-seq

Swati Parekh et al.

SCIENTIFIC REPORTS (2016)

Article Biochemistry & Molecular Biology

Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets

Evan Z. Macosko et al.

Article Multidisciplinary Sciences

Functional heterogeneity of human memory CD4+ T cell clones primed by pathogens or vaccines

Simone Becattini et al.

SCIENCE (2015)

Article Biochemistry & Molecular Biology

The Somatic Genomic Landscape of Glioblastoma

Cameron W. Brennan et al.

Article Multidisciplinary Sciences

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

Christiane A. Opitz et al.

NATURE (2011)

Article Multidisciplinary Sciences

Generation of pathogenic TH17 cells in the absence of TGF-β signalling

Kamran Ghoreschi et al.

NATURE (2010)

Review Immunology

T(H)17 cells in tumour immunity and immunotherapy

Weiping Zou et al.

NATURE REVIEWS IMMUNOLOGY (2010)

Review Immunology

IL-17 and Th17 Cells

Thomas Korn et al.

ANNUAL REVIEW OF IMMUNOLOGY (2009)

Article Immunology

IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway

Lin Wang et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2009)

Article Multidisciplinary Sciences

Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor

Francisco J. Quintana et al.

NATURE (2008)

Article Multidisciplinary Sciences

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

A Subramanian et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Hematology

Interleukin-17 promotes angiogenesis and tumor growth

M Numasaki et al.

BLOOD (2003)